Granules Pharmaceuticals Inc. recalls
5 notices naming Granules Pharmaceuticals Inc. as the recalling firm, since January 15, 2025. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Granules Pharmaceuticals Inc.: Trazodone Hydrochloride
Hazard (FDA): Presence of Foreign Tablets/Capsules
FDAMedicines
Granules Pharmaceuticals Inc.: Dextroamphetamine Saccharate and 4 more
Hazard (FDA): Failed Impurities/Degradation Specifications:
FDAMedicines
Dissolution
Granules Pharmaceuticals Inc.: Metoprolol Succinate Extended-Release Tablets
Hazard (FDA): Failed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH) long-term.
FDAMedicines
Granules Pharmaceuticals Inc.: Metformin Hydrochloride Extended-Release Tablets
Hazard (FDA): Presence of Foreign Tablets/Capsules: A Paracetamol 500 mg tablet was found in a 1000-count bottle of Metformin HCL ER Tablets USP, 500 mg.
FDAMedicines
Dissolution
Granules Pharmaceuticals Inc.: Colchicine Capsules 0.6 mg
Hazard (FDA): Failed Dissolution Specifications: Out of specification observed during the accelerated stability conditions for the 30 count bottles.
FDAMedicines